Ipca Laboratories Limited (IPCALAB.NS)
INR 1378.2
(-1.64%)
INR 1378.2
(-1.64%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 29.59 Billion INR | 19.19% |
| 2022 | 7.03 Billion INR | -33.59% |
| 2021 | 10.59 Billion INR | -19.44% |
| 2020 | 13.14 Billion INR | 77.14% |
| 2019 | 7.42 Billion INR | 39.64% |
| 2018 | 5.31 Billion INR | 87.4% |
| 2017 | 2.83 Billion INR | 6.78% |
| 2016 | 2.65 Billion INR | 49.19% |
| 2015 | 1.78 Billion INR | -51.82% |
| 2014 | 3.69 Billion INR | -48.3% |
| 2013 | 7.14 Billion INR | 31.83% |
| 2012 | 5.42 Billion INR | 19.87% |
| 2011 | 4.52 Billion INR | 21.53% |
| 2010 | 3.72 Billion INR | 25.88% |
| 2009 | 2.95 Billion INR | 96.9% |
| 2008 | 1.5 Billion INR | -23.27% |
| 2007 | 1.95 Billion INR | 10.67% |
| 2006 | 1.76 Billion INR | 101.18% |
| 2005 | 878.72 Million INR | -12.65% |
| 2004 | 1 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 2.93 Billion INR | 879.39% |
| 2023 FY | 8.38 Billion INR | 19.19% |
| 2023 Q1 | 2.38 Billion INR | 61.17% |
| 2023 Q2 | 2.69 Billion INR | 13.06% |
| 2023 Q3 | 2.54 Billion INR | -5.64% |
| 2023 Q4 | 981.5 Million INR | -61.4% |
| 2022 Q2 | 2.33 Billion INR | 12.34% |
| 2022 Q3 | 1.8 Billion INR | -22.71% |
| 2022 Q4 | 1.47 Billion INR | -17.92% |
| 2022 FY | 7.03 Billion INR | -33.59% |
| 2022 Q1 | 2.07 Billion INR | 47.59% |
| 2021 Q4 | 1.4 Billion INR | -43.57% |
| 2021 Q1 | 3.6 Billion INR | 122.99% |
| 2021 Q2 | 3.08 Billion INR | -14.43% |
| 2021 Q3 | 2.49 Billion INR | -19.27% |
| 2021 FY | 10.59 Billion INR | -19.44% |
| 2020 FY | 13.14 Billion INR | 77.14% |
| 2020 Q4 | 1.61 Billion INR | -48.39% |
| 2020 Q3 | 3.13 Billion INR | 1.4% |
| 2020 Q2 | 3.09 Billion INR | -42.48% |
| 2020 Q1 | 5.37 Billion INR | 251.19% |
| 2019 FY | 7.42 Billion INR | 39.64% |
| 2019 Q4 | 1.52 Billion INR | -31.34% |
| 2019 Q3 | 2.22 Billion INR | 3.05% |
| 2019 Q2 | 2.16 Billion INR | 41.68% |
| 2019 Q1 | 1.52 Billion INR | 4.95% |
| 2018 Q2 | 1.28 Billion INR | 79.13% |
| 2018 Q1 | 719.8 Million INR | 0.0% |
| 2018 FY | 5.31 Billion INR | 87.4% |
| 2018 Q4 | 1.45 Billion INR | -22.94% |
| 2018 Q3 | 1.88 Billion INR | 46.36% |
| 2017 FY | 2.83 Billion INR | 6.78% |
| 2016 FY | 2.65 Billion INR | 49.19% |
| 2015 FY | 1.78 Billion INR | -51.82% |
| 2014 FY | 3.69 Billion INR | -48.3% |
| 2013 FY | 7.14 Billion INR | 31.83% |
| 2012 FY | 5.42 Billion INR | 19.87% |
| 2011 FY | 4.52 Billion INR | 21.53% |
| 2010 FY | 3.72 Billion INR | 25.88% |
| 2009 FY | 2.95 Billion INR | 96.9% |
| 2008 FY | 1.5 Billion INR | -23.27% |
| 2007 FY | 1.95 Billion INR | 10.67% |
| 2006 FY | 1.76 Billion INR | 101.18% |
| 2005 FY | 878.72 Million INR | -12.65% |
| 2004 FY | 1 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Amrutanjan Health Care Limited | 621.02 Million INR | -4665.735% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -143182.823% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | -309.623% |
| FDC Limited | 3.03 Billion INR | -875.578% |
| Gufic Biosciences Limited | 2.89 Billion INR | -922.754% |
| Hikal Limited | 1.49 Billion INR | -1880.759% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -1373.171% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | -498.853% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -14125.667% |
| Medico Remedies Limited | 277.11 Million INR | -10580.107% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -660.72% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -5265.68% |
| RPG Life Sciences Limited | 2.29 Billion INR | -1191.127% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Shilpa Medicare Limited | 3.76 Billion INR | -686.812% |
| Sigachi Industries Limited | 1.47 Billion INR | -1908.045% |
| Themis Medicare Limited | 1.3 Billion INR | -2171.229% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Venus Remedies Limited | 534.65 Million INR | -5435.667% |
| Wanbury Limited | 1.7 Billion INR | -1633.621% |
| ZIM Laboratories Limited | 1.09 Billion INR | -2595.214% |
| Lupin Limited | 27.75 Billion INR | -6.623% |
| Innova Captab Limited | 2.53 Billion INR | -1068.248% |
| Ind-Swift Limited | 1.22 Billion INR | -2314.141% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 71.679% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 868.162% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -561.537% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -107688.258% |
| Morepen Laboratories Limited | 4.17 Billion INR | -609.097% |
| Laurus Labs Limited | 3.94 Billion INR | -649.544% |
| Aarti Drugs Limited | 7.14 Billion INR | -314.011% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | -229.612% |
| Alembic Limited | 767.77 Million INR | -3754.865% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -413.998% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -355.164% |
| Vaishali Pharma Limited | 6.29 Million INR | -470133.556% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -846.145% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -13727.556% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -470.37% |
| Eris Lifesciences Limited | 5.18 Billion INR | -471.171% |
| Windlas Biotech Limited | 1.29 Billion INR | -2178.599% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 71.625% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -1452.54% |
| Orchid Pharma Limited | 2.36 Billion INR | -1153.516% |
| Albert David Limited | 1.33 Billion INR | -2117.868% |
| Hester Biosciences Limited | 364.77 Million INR | -8013.743% |
| Sakar Healthcare Limited | 495.5 Million INR | -5872.985% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -542.335% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -962.33% |
| Divi's Laboratories Limited | 18.31 Billion INR | -61.641% |
| Mankind Pharma Limited | 40.86 Billion INR | 27.58% |
| Neuland Laboratories Limited | 5.31 Billion INR | -456.525% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | -292.441% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 34.798% |
| Wockhardt Limited | 140 Million INR | -21040.357% |
| Bal Pharma Limited | 214.56 Million INR | -13693.465% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 56.302% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -2304.263% |
| Alkem Laboratories Limited | 19.46 Billion INR | -52.074% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 19.67 Billion INR | -50.409% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -12353.242% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -1045407.566% |
| Granules India Limited | 6.52 Billion INR | -353.36% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Brooks Laboratories Limited | -72.25 Million INR | 41062.88% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -11774.175% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | -16.82% |
| NATCO Pharma Limited | 25.96 Billion INR | -13.999% |
| Suven Life Sciences Limited | -1.22 Billion INR | 2514.421% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | -466.352% |
| Indoco Remedies Limited | 1.52 Billion INR | -1841.518% |
| Alpa Laboratories Limited | 61.51 Million INR | -48012.655% |
| Lasa Supergenerics Limited | -458 Million INR | 6562.047% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 819.227% |